VISTN — Vistin Pharma ASA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Annual balance sheet for Vistin Pharma ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	—	—	—	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	77	35.7	1.44	26.2	12.8
Net Total Accounts Receivable
Net Total Receivables	32.7	43.1	71.2	59.6	52
Total Inventory
Prepaid Expenses
Total Current Assets	142	138	159	169	143
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	145	167	219	220	230
Long Term Investments
Other Long Term Assets
Total Assets	322	333	407	403	385
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	32.2	41	118	69.5	64
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	49.5	57.4	134	80.6	75.4
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	272	276	273	323	310
Total Liabilities & Shareholders' Equity	322	333	407	403	385
Total Common Shares Outstanding